Pharmacy Compounding Accreditation
PCAB (Pharmacy Compounding Accreditation Board) accreditation is the pharmacy profession's standard of distinction for sterile and non-sterile compounding quality. Affinity QMS provides the quality management infrastructure — document control, CAPA, audit management, validation, and training records — that PCAB surveyors evaluate during compounding pharmacy accreditation surveys.
Overview
PCAB (Pharmacy Compounding Accreditation Board) is the nationally recognized accreditation program for compounding pharmacies in the United States. Founded in 2004, PCAB is now operated under the umbrella of ACHC (Accreditation Commission for Health Care) and establishes quality and safety standards for both sterile and non-sterile pharmaceutical compounding. PCAB accreditation signals to prescribers, patients, hospitals, and health systems that a compounding pharmacy has been independently evaluated against rigorous quality standards that go beyond state board of pharmacy licensure requirements.
PCAB accreditation has become an increasingly important market differentiator and, in many cases, a procurement requirement. Major hospital systems and integrated delivery networks (IDNs) increasingly require PCAB accreditation or equivalent quality evidence from compounding pharmacies and 503B outsourcing facilities in their vendor credentialing processes. Group purchasing organizations (GPOs) such as Vizient, Premier, and HealthTrust have included PCAB accreditation in their supplier qualification frameworks. As a result, compounding pharmacies that want access to hospital and health system purchasing relationships frequently cannot avoid PCAB accreditation.
PCAB's accreditation standards are built on USP chapters — primarily USP <795> (non-sterile compounding), USP <797> (sterile compounding), and USP <800> (hazardous drugs) — as well as PCAB-specific quality management requirements covering documentation, personnel qualifications, quality control procedures, and continuous quality improvement. PCAB surveyors conduct on-site surveys that evaluate both compliance with USP standards and the maturity of the pharmacy's quality management system.
Key Distinctions
Traditional Compounding
Section 503A of the FD&C Act governs traditional compounding pharmacies that prepare customized medications based on individual patient-specific prescriptions. 503A pharmacies are primarily regulated by state boards of pharmacy rather than FDA, though they must comply with USP <795> and USP <797> as applicable. 503A pharmacies may not compound in large volumes anticipating demand, may not commercially distribute beyond the prescribing state, and are not required to register with FDA. PCAB accreditation for 503A pharmacies demonstrates quality system maturity beyond state licensure and is increasingly required by hospitals that send individual patient prescriptions to specialty compounders.
FDA-Regulated Outsourcing
Section 503B of the FD&C Act creates a pathway for compounding pharmacies to become FDA-registered "outsourcing facilities" that can produce larger volumes of compounded sterile products (CSPs) for distribution to healthcare providers without patient-specific prescriptions. 503B facilities are subject to FDA cGMP oversight under 21 CFR Part 211, regular FDA inspections, and USP <797> and <800> requirements. They have higher quality system burdens than 503A facilities. PCAB accreditation for 503B facilities demonstrates that the facility's quality management system meets the highest standards in the compounding industry and is a significant competitive differentiator in hospital procurement.
Platform Mapping
| PCAB Requirement | Standard Reference | Affinity QMS Module | What It Does |
|---|---|---|---|
| Policy and Procedure Documentation | PCAB §4 / USP <797> | Document Control | Controlled SOPs for compounding procedures, BUD policies, environmental monitoring SOPs, and quality control procedures with version history, pharmacist approval, and distribution to all relevant compounding staff |
| Deviation and CAPA Management | PCAB §7 CQI | CAPA Management | Compounding deviation records, out-of-specification investigation workflows, environmental monitoring excursion CAPA, and continuous quality improvement (CQI) program documentation aligned to PCAB CQI requirements |
| Quality Surveys and Internal Audits | PCAB §7 / ACHC | Audit Management | Internal quality survey schedules mapped to PCAB standards, finding documentation, corrective action tracking, and mock PCAB survey workflows to prepare staff for the on-site surveyor visit |
| Personnel Training and Qualification | PCAB §3 / USP <797> §5 | Training Management | Pharmacist and technician training records, aseptic technique competency assessments (media fill test documentation), gloved fingertip sampling records, ongoing competency monitoring, and PCQI-equivalent pharmacist qualification records |
| Validation Protocols | USP <797> / 21 CFR 211 | Validation Engine | Cleaning validation, process validation, and equipment qualification (IQ/OQ/PQ) protocol generation and management for compounding equipment, isolators, LAFW, and CACI systems |
| Deviation Records | PCAB §6 | CAPA Management | Batch deviation records, complaint records linked to compounded preparations, and recall documentation with full traceability from the deviation event through corrective action implementation and verification |
Who This Is For
Director of Pharmacy at a 503B Facility
503B outsourcing facilities preparing sterile CSPs at scale need a QMS that satisfies both FDA cGMP expectations (21 CFR Part 211) and PCAB accreditation standards simultaneously — without running two separate documentation systems. Affinity QMS manages both from a single configured platform.
Pharmacist-in-Charge at a Sterile Compounding Pharmacy
503A sterile compounding pharmacies pursuing PCAB accreditation to meet hospital purchasing requirements need a structured QMS that documents SOPs, staff training, environmental monitoring CAPA, and quality surveys in a format that PCAB surveyors can review and verify during the on-site accreditation survey.
VP Quality at a Compounding Pharmacy Chain
Multi-location compounding pharmacy organizations maintaining PCAB accreditation across multiple sites need a centralized QMS where SOPs are controlled and distributed across all locations, training records are maintained per facility, and internal audit findings are tracked organization-wide with site-level corrective action management.
Common Questions
How does PCAB accreditation relate to FDA 503B registration?
PCAB accreditation and FDA 503B registration are separate, parallel programs that address different aspects of compounding pharmacy oversight. FDA 503B registration is a regulatory designation granted by FDA that allows a compounding pharmacy to become an outsourcing facility — legally permitted to compound larger volumes of CSPs for distribution to healthcare providers without patient-specific prescriptions. It comes with FDA inspection authority and cGMP obligations under 21 CFR Part 211. PCAB accreditation is a voluntary third-party quality accreditation awarded by ACHC/PCAB based on meeting PCAB's quality management standards. A facility can be FDA-registered as a 503B outsourcing facility without PCAB accreditation, and a facility can be PCAB-accredited without being a 503B registered facility. Many hospitals require both as conditions of their supplier approval processes, viewing 503B registration as the regulatory baseline and PCAB accreditation as the quality overlay.
How long does PCAB accreditation take to obtain?
The PCAB accreditation process typically takes six to twelve months from initial application to certificate issuance for a compounding pharmacy starting from a mature quality system. Pharmacies without documented quality systems should plan for twelve to eighteen months of preparation. The process involves a self-assessment against PCAB standards, submission of an application and documentation package to ACHC, a desktop document review, an on-site survey by PCAB-credentialed surveyors, corrective action resolution for any deficiencies found, and final accreditation committee review. Accreditation, once awarded, is valid for three years with ongoing monitoring requirements between surveys. Affinity QMS compresses the preparation phase by providing pre-configured compounding pharmacy QMS templates aligned to PCAB's standards and USP <797>/<800>.
Do hospitals actually require PCAB accreditation from compounding pharmacies?
Yes, and the trend is accelerating. Major hospital systems and health systems — particularly those with robust pharmacy procurement standards — increasingly require PCAB accreditation or equivalent quality evidence as a condition of vendor qualification. Organizations including academic medical centers, IDNs, and safety-net hospitals have added PCAB accreditation requirements to their compounding pharmacy vendor credentialing checklists. GPOs representing hospital purchasing consortia have incorporated PCAB accreditation into their preferred vendor frameworks. For 503B outsourcing facilities targeting hospital customers, PCAB accreditation has shifted from a market differentiator to a de facto market-access requirement in many segments of the hospital pharmacy supply chain.
What is the difference between sterile and non-sterile PCAB accreditation?
PCAB offers separate accreditation for sterile compounding and non-sterile compounding, reflecting the significantly different risk profiles and operational requirements of each. Sterile compounding accreditation (governed by USP <797>) involves more rigorous requirements for facility design (ISO cleanrooms), environmental monitoring, personnel aseptic technique qualification, and sterility testing. Non-sterile compounding accreditation (governed by USP <795>) addresses documentation, ingredient quality, training, and quality control for preparations such as topical creams, ointments, oral liquids, and capsules. A pharmacy seeking to compound both sterile and non-sterile preparations must achieve accreditation in both categories. The quality management system requirements overlap significantly between the two, making a unified QMS platform like Affinity QMS more efficient than managing separate documentation systems for sterile and non-sterile programs.
What are the most common PCAB deficiency findings during surveys?
Based on patterns in compounding pharmacy accreditation, the most common areas generating deficiency findings during PCAB surveys are: personnel training and competency records that are incomplete or lack evidence of periodic reassessment; environmental monitoring programs where action levels are not clearly defined or where excursion investigations are not consistently documented with root cause and corrective action; SOPs that are outdated, missing required elements, or not reviewed on the required schedule; quality audit programs that exist on paper but show no evidence of completed audits or closed findings; and deviation records that lack root cause analysis or do not consistently capture all out-of-specification events. Affinity QMS is specifically configured to prevent all five of these deficiency patterns through automated review reminders, structured CAPA workflows, and document version control that enforces review schedules.
Can Affinity QMS handle both PCAB accreditation and FDA 503B inspection requirements?
Yes. Affinity QMS is configured for 503B outsourcing facilities to address both FDA cGMP requirements (21 CFR Part 211) and PCAB accreditation standards simultaneously within a single quality management platform. The Document Control module manages master batch records, compounding SOPs, and environmental monitoring procedures to 21 CFR Part 211 controlled document standards. The CAPA module handles both FDA-expected OOS investigations and PCAB's CQI-aligned non-conformance management. The Validation Engine manages IQ/OQ/PQ protocols for compounding equipment — a FDA 21 CFR Part 211 expectation that PCAB surveyors also evaluate. The Training module tracks the aseptic technique competency records required by both FDA (as part of cGMP) and PCAB (as part of their personnel qualification standards). One platform, two oversight bodies, no duplication of effort.
Related Resources
See how Affinity QMS provides compounding pharmacies and 503B outsourcing facilities with the complete QMS infrastructure that PCAB surveyors and FDA inspectors evaluate — from SOPs through CAPA through validation records.
Book a Demo